Furthermore, we demonstrated that combination treatment with RA and a PHD inhibitor increases the EPO production in ex vivo tissue cultures of adult mouse kidneys and that the PHD inhibitor improves renal anemia in the presence of RA in CKD mouse models. Here, EPO is linked to chronic kidney disease.